Decoding SHP2 mutations by computational saturation mutagenesis.

Authors

Chen Wang, Xiao Tang, Qiaobin Yao, Ao Qi, Jie Zheng, Xingxu Huang, Shaolei Teng, Gaofeng Fan

Published in

Journal of molecular cell biology. Jul 17, 2026. Epub Jul 17, 2026.

Abstract

Src-homology-2-containing protein tyrosine phosphatase 2 (SHP2), encoded by the PTPN11 gene, is a master regulator of cell growth, survival, and differentiation. Normally, SHP2 is kept in a self-inhibited state, in which its N-terminal SH2 domain blocks the catalytic site. SHP2 activation is directly tied to the disruption of the self-inhibition. While mutations that disrupt this self-inhibited state can cause developmental disorders and cancer, most SHP2 variants remain functionally uncharacterized. Using computational saturation mutagenesis, we systematically analyzed > 9000 single-amino acid substitutions in the SH2 and PTP domains. Our analysis of binding energy changes identified key residues-especially A72 and G503-whose mutation destabilizes the autoinhibited conformation. Functional assays further demonstrated that mutations within the SH2 and PTP domains significantly enhance enzymatic activity, downstream signaling, and cellular proliferation. By integrating clinical data, we found that pathogenic variants preferentially adopt the destabilizing conformations, directly linking structural changes to disease. This work provides a comprehensive map of SHP2 mutation effects, highlights conformational opening as a key driver of pathogenicity, and establishes a predictive framework for interpreting the functional impact of uncharacterized variants in multi-domain proteins.

PMID:
42466850
Bibliographic data and abstract were imported from PubMed on 17 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.